EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Hospital Arnau de Vilanova
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Arnau de Vilanova (10)
2021
-
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study
Frontiers in Oncology, Vol. 11
-
Long-Term Cardiac Safety and Survival Outcomes of Neoadjuvant Pegylated Liposomal Doxorubicin in Elderly Patients or Prone to Cardiotoxicity and Triple Negative Breast Cancer. Final Results of the Multicentre Phase II CAPRICE Study
Frontiers in Oncology, Vol. 11
-
The role of CDK4/6 inhibitors in early breast cancer
Breast, Vol. 58, pp. 160-169
2020
-
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
The Lancet Oncology, Vol. 21, Núm. 11, pp. 1455-1464
-
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
-
Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer
Future Oncology, Vol. 16, Núm. 33, pp. 2763-2778
-
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
The Lancet Oncology, Vol. 21, Núm. 1, pp. 33-43
2019
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428
2006
-
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: Efficacy and correlation with HER2 extracellular domain
Clinical and Translational Oncology, Vol. 8, Núm. 12, pp. 896-902